Home6919 • TPE
add
Caliway Biopharmaceuticals Co Ltd
Nakaraang pagsara
NT$1,240.00
Sakop ng araw
NT$1,175.00 - NT$1,250.00
Sakop ng taon
NT$436.00 - NT$1,405.00
Market cap
188.45B TWD
Average na Volume
1.63M
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (TWD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 227.48M | -6.62% |
Net na kita | -175.56M | 19.64% |
Net profit margin | — | — |
Kita sa bawat share | -1.10 | — |
EBITDA | -221.97M | 5.84% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (TWD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 9.55B | 169.12% |
Kabuuang asset | 9.66B | 164.37% |
Kabuuang sagutin | 95.36M | -23.10% |
Kabuuang equity | 9.56B | — |
Natitirang share | 154.61M | — |
Presyo para makapag-book | 20.05 | — |
Return on assets | -5.85% | — |
Return on capital | -5.90% | — |
Cash Flow
Net change in cash
| (TWD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -175.56M | 19.64% |
Cash mula sa mga operasyon | -118.07M | 26.31% |
Cash mula sa pag-invest | 2.51B | 277,414.14% |
Cash mula sa financing | 4.16M | 471.10% |
Net change in cash | 2.40B | 1,575.70% |
Malayang cash flow | -88.28M | 5.38% |
Tungkol
Itinatag
2012
Website
